Taiwan is intensifying efforts in generic drug development to strengthen the global competitiveness of its pharmaceutical ...

Drugs reviewed by the FDA under programs intended to speed drug development were approved nearly a year more quickly than drugs reviewed through the agency's normal processes.

On consecutive days, the FDA announced 2 more strategies to help novel drugs reach more patients. One plan will encourage competition by providing more guidance to developers of complex generics ...

Generic drugs are cheap and effective alternatives of branded drugs but require strict quality and risk assessment. Based on the lately endorsed “quality by design” (QbD) concept, researchers ...